Sab Biotherapeutics Inc (NQ: SABS )
2.400
-0.120
(-4.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 11, 2024
Add to My Watchlist
All News about Sab Biotherapeutics Inc
Via Benzinga
SAB BIO Appoints Lucy To as Chief Financial Officer
July 31, 2024
Via GlobeNewswire
SAb Biotherapeutics Rebrands as SAB BIO
June 20, 2024
Via GlobeNewswire
Via Benzinga
Via Benzinga
Via Benzinga
SAB Biotherapeutics Provides SAB-142 Trial Update
April 16, 2024
Via GlobeNewswire
SAB Biotherapeutics to Present at INNODIA Annual Meeting
April 08, 2024
Via GlobeNewswire
SAB Biotherapeutics to Present at the BIO CEO & Investor Conference
February 23, 2024
Via GlobeNewswire
SAB Biotherapeutics Announces Executive Leadership Change
February 02, 2024
Via GlobeNewswire
SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split
January 02, 2024
Via GlobeNewswire
VerifyMe And 3 Other Stocks Under $2 Insiders Are Buying
December 01, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.